Cargando…
ATM/RB1 mutations predict shorter overall survival in urothelial cancer
BACKGROUND: Mutations of DNA repair genes, e.g. ATM/RB1, are frequently found in urothelial cancer (UC) and have been associated with better response to cisplatin-based chemotherapy. Further external validation of the prognostic value of ATM/RB1 mutations in UC can inform clinical decision making an...
Autores principales: | Yin, Ming, Grivas, Petros, Emamekhoo, Hamid, Mendiratta, Prateek, Ali, Siraj, Hsu, JoAnn, Vasekar, Monali, Drabick, Joseph J., Pal, Sumanta, Joshi, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908293/ https://www.ncbi.nlm.nih.gov/pubmed/29682192 http://dx.doi.org/10.18632/oncotarget.24738 |
Ejemplares similares
-
Relationship of smoking status to genomic profile, chemotherapy response and clinical outcome in patients with advanced urothelial carcinoma
por: Joshi, Monika, et al.
Publicado: (2016) -
Alterations of DNA damage response genes correlate with response and overall survival in anti‐PD‐1/PD‐L1‐treated advanced urothelial cancer
por: Joshi, Monika, et al.
Publicado: (2020) -
Improving Outcomes for Patients With Advanced Urothelial Carcinoma
por: Grivas, Petros, et al.
Publicado: (2020) -
Emerging biomarkers in urothelial carcinoma: Challenges and opportunities
por: Andreatos, Nikolaos, et al.
Publicado: (2020) -
Surrogate Endpoints as Predictors of Overall Survival in Metastatic Urothelial Cancer: A Trial-level Analysis
por: Ghali, Fady, et al.
Publicado: (2022)